Chancellor Reeves Intends Focused Measures on Household Expenses in Forthcoming Financial Plan
Chancellor Rachel Reeves has revealed she is preparing "targeted action to tackle cost of living issues" in the forthcoming Budget.
Speaking to the BBC, she emphasized that lowering price rises is a shared duty of both the administration and the Bank of England.
The United Kingdom's inflation rate is projected to be the highest among the G7 advanced economies this calendar year and the following year.
Potential Energy Bill Measures
Reports indicate the administration could intervene to lower utility costs, for example by reducing the present 5% level of VAT charged on energy supplies.
Another possibility is to reduce some of the regulatory levies currently included in household expenses.
Fiscal Constraints and Analyst Predictions
The government will receive the next draft from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much scope there is for these measures.
The view from most analysts is that the Chancellor will have to announce higher taxes or spending cuts in order to fulfill her self-imposed debt limits.
Previously on Thursday, calculations indicated there was a ÂŁ22 billion shortfall for the chancellor to resolve, which is at the lower end of projections.
"It is a joint task between the central bank and the administration to continue tackling some of the drivers of inflation," Reeves informed reporters in Washington, at the conferences of the IMF and World Bank.
Tax Pledges and Global Issues
While a great deal of the attention has been on likely tax increases, the chancellor said the latest data from the OBR had not changed her vow to campaign commitments not to raise rates on earnings tax, VAT or social security contributions.
She attributed an "unpredictable world" with rising geopolitical and trade tensions for the Budget revenue measures, probably to be targeted on those "with the broadest shoulders."
Global Trade Disputes
Addressing concerns about the United Kingdom's economic relations with China she said: "Our security interests invariably come first."
Last week's declaration by Chinese authorities to tighten export controls on rare earths and other materials that are essential for high-technology production led US President the US President to propose an extra 100% import tax on goods from the Asian country, increasing the prospect of an all-out trade war between the two largest economies.
The US Treasury Secretary called China's action "commercial pressure" and "a international production power grab."
Asked about accepting the American proposal to join its dispute with China, the Chancellor said she was "deeply worried" by Chinese actions and urged the Beijing authorities "not to put up barriers and restrict access."
She said the move was "harmful for the international commerce and causes additional obstacles."
"It is my opinion there are fields where we should confront Chinese policies, but there are also significant prospects to sell into Chinese markets, including financial services and other sectors of the economic system. We've got to maintain that balance appropriate."
The chancellor also stated she was collaborating with G7 counterparts "on our own essential resources strategy, so that we are less reliant."
Health Service Medicine Pricing and Investment
The Chancellor also acknowledged that the cost the National Health Service spends on medicines could increase as a consequence of ongoing talks with the US government and its drugs companies, in exchange for lower tariffs and investment.
Some of the world's largest pharmaceutical manufacturers have said lately that they are either halting or canceling operations in the United Kingdom, with some blaming the insufficient payments they are receiving.
Last month, the government science advisor said the price the NHS pays for drugs would need to increase to halt firms and pharmaceutical investment leaving the UK.
The Chancellor stated to the BBC: "We have seen as a result of the cost structure, that drug testing, recent pharmaceuticals have not been available in the United Kingdom in the extent that they are in other European countries."
"We want to ensure that people getting treatment from the NHS are able to obtain the top life-saving medicines in the world. And so we are looking at this situation, and... aiming to obtain more investment into Britain."